GQ Bio Closes Collaboration Deal with Pacira BioSciences for Development of a Commercial-Scale Manufacturing Process for High-Capacity Adenoviral Vectors
GQ Bio Therapeutics GmbH today announced that it has closed a collaboration deal with Pacira BioSciences, Inc. for the development of a manufacturing process for its High-Capacity Adenoviral vector (HCAd) gene therapy product candidate, PCRX-201,…